Skip to main content
Hofseth BioCare ASA (OSL: HBC)
Norway flag Norway · Delayed Price · Currency is NOK
1.720
+0.120 (7.50%)
Dec 27, 2024, 4:27 PM CET

Hofseth BioCare ASA Revenue

Hofseth BioCare ASA had revenue of 67.89M NOK in the quarter ending September 30, 2024, with 36.08% growth. This brings the company's revenue in the last twelve months to 248.08M, up 21.19% year-over-year. In the year 2023, Hofseth BioCare ASA had annual revenue of 218.51M with 81.42% growth.

Revenue (ttm)
248.08M
Revenue Growth
+21.19%
P/S Ratio
2.82
Revenue / Employee
3.54M
Employees
71
Market Cap
707.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023218.51M98.06M81.42%
Dec 31, 2022120.45M32.83M37.47%
Dec 31, 202187.62M18.36M26.52%
Dec 31, 202069.25M1.47M2.17%
Dec 31, 201967.78M7.04M11.59%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nordhealth AS 513.12M
Medistim ASA 541.82M
Photocure ASA 526.25M
Carasent ASA 264.80M
Nykode Therapeutics AS 46.02M
ArcticZymes Technologies ASA 110.76M
Gentian Diagnostics ASA 154.12M
Navamedic ASA 525.55M
Revenue Rankings

Hofseth BioCare ASA News

More News